Combination treatment with plasmapheresis and sirolimus does not seem to benefit nephrogenic systemic fibrosis

International Journal of Artificial Organs

Volumn 31, Issue 10, 2008, Pages 913-914

  Tsagalis, G ^a   Psimenou, E ^a   Laggouranis, A ^a  

^a ALEXANDRA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COMBINATION TREATMENTS; NEPHROGENIC SYSTEMIC FIBROSIS; SIROLIMUS;

RAPAMYCIN;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL EXAMINATION; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS PATIENT; HISTOPATHOLOGY; HUMAN; KIDNEY FIBROSIS; LABORATORY TEST; LETTER; NEPHROGENIC SYSTEMIC FIBROSIS; PATIENT REFERRAL; PLASMAPHERESIS; SKIN BIOPSY; SKIN SWELLING;

EID: 59549100835     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803101009     Document Type: Letter

References (3)

1. Nortier JL, Del Marmol V. Nephrogenic systemic fibrosis-the need for a multidisciplinary approach (2007). Nephrol Dial Transplant 2007; 22: 3097-101.
2. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis. Nephrol Dial Transplant 2006; 21: 1104-8.
3. Knopp EA, Cowper SE. Nephrogenic Systemic Fibrosis: Early Recognition and Treatment. Semin Dial 2008; 21: 123-128.